Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G.   Blessing J.A.   Ball H.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 346-349

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Hydroxyurea, Dacarbazine (DTIC), and Etoposide (VP-16) in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study

By Currie J.L.   Blessing J.A.   McGehee R.   Soper J.T.   Berman M.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 94-96

Academic Press

Access to resources Recommend Favorite

Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology Group

By Smith H.O.   Blessing J.A.   Vaccarello L.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 140-144

Elsevier

Access to resources Recommend Favorite

Prolonged Oral Etoposide in Recurrent or Advanced Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Soper J.T.   Barter J.F.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 267-271

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Lewandowski G.S.   Creasman W.T.   Webster K.D.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 101-104

Academic Press

Access to resources Recommend Favorite